/NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN
The exercise price of the Warrants is being repriced to CDN
The Company will deliver a new exercise notice (the “New Exercise Notice”) to the Warrantholders for exercise during the Warrant Repricing Period. All Warrantholders who wish to exercise their Warrants during the Warrant Repricing Period will be required to surrender their respective Warrant Certificates representing their Warrants, along with a properly completed New Exercise Notice to the Company, in accordance with the instructions provided in the New Exercise Notice.
Table: List of warrant series subject to repricing:
Date of Issuance | Number of Warrants Outstanding (not held by Insiders) | Original Exercise Price | Expiry Date | |
4,808,101 | $ 0.30 | |||
2,232,200 | $ 0.30 | |||
77,000 | ||||
9,975,228 | $ 0.48 | |||
13,279,269 | $ 0.48 | |||
280,000 | $ 0.48 | |||
9,939,066 | $ 0.35 | |||
3,591,666 | $ 0.35 | |||
Total: | 44,182,530 |
The securities referred to in this news release have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within
About
For further information:
Visit us at www.promisneurosciences.com or follow us on Twitter and LinkedIn
For media inquiries, please contact:
shanti.skiffington@gmail.com
Tel. 617 921-0808
For Investor Relations, please contact:
nick@alpineequityadv.com
Tel. 617 901-0785
The TSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This information release contains certain forward-looking information, including about the timing and completion of the Warrant Repricing and the receipt of TSX approval. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company's current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its public securities filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Source:
2020 GlobeNewswire, Inc., source